Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Sattar N, Murray HM, Welsh P, Blauw GJ, Buckley BM, Cobbe S, de Craen AJ, Lowe GD, Jukema JW, Macfarlane PW, Murphy MB, Stott DJ, Westendorp RG, Shepherd J, Ford I, Packard CJ; Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group.
Sattar N, et al. Among authors: welsh p.
PLoS Med. 2009 Jun 23;6(6):e1000099. doi: 10.1371/journal.pmed.1000099. Epub 2009 Jun 23.
PLoS Med. 2009.
PMID: 19554082
Free PMC article.
Clinical Trial.